National Center for Advancing Translational Sciences in Massachusetts
National Center for Advancing Translational Sciences (93.350) awarded $239 million to recipients in Massachusetts in 69 grants from fiscal 2021 to 2025, 7.7% of the program's national total. President and Fellows of Harvard College received the most, $68.4 million.
- Awarded in Massachusetts$239 million
- Awards69
- Share of the program7.7%
- Rank among states3rd of 41
- National total$3.1 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 33 | $54.6 million |
| FY 2022 | 29 | $49.7 million |
| FY 2023 | 35 | $52.1 million |
| FY 2024 | 28 | $47.8 million |
| FY 2025 | 17 | $34.3 million |
Recipients in Massachusetts
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| President and Fellows of Harvard College | Colleges and universities | 8 | $68.4 million |
| Trustees of Tufts College | Colleges and universities | 8 | $65.8 million |
| Trustees of Boston University | Colleges and universities | 3 | $30.9 million |
| University of Massachusetts Medical School | Colleges and universities | 3 | $24.6 million |
| Brigham & Womens Hospital Inc | Nonprofits | 6 | $15.3 million |
| The Children's Hospital Corporation | Nonprofits | 9 | $9.8 million |
| Tufts Medical Center Parent, Inc. | Nonprofits | 1 | $3.1 million |
| Javelin Biotech Inc | Small businesses | 2 | $2.2 million |
| Emmune Inc | Small businesses | 1 | $2.1 million |
| Strm.bio Incorporated | Small businesses | 1 | $2.1 million |
Open opportunities under this program
- Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
- Limited Competition: NCATS Clinical and Translational Science Award (CTSA) Program Research Education Grants Programs (R25 - Clinical Trial Not Allowed)
- Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
- Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
- NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
- Clinical and Translational Science Award (UM1 Clinical Trial Optional)
- Limited Competition: Mentored Research Career Development Program Award in Clinical and Translational Science Awards (CTSA) Program (K12 Clinical Trial Optional)
See all 34 on the program page
Questions people ask
How much National Center for Advancing Translational Sciences money goes to Massachusetts?
$239 million from fiscal 2021 to 2025, across 69 awards. Massachusetts ranks 3rd of 41 states and territories for this program.
Who receives National Center for Advancing Translational Sciences money in Massachusetts?
The largest recipient is President and Fellows of Harvard College, with $68.4 million in 8 awards. Next are Trustees of Tufts College and Trustees of Boston University.
Can organizations in Massachusetts apply now?
Yes, 34 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
National Center for Advancing Translational Sciences in other states
Other large programs in Massachusetts
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- Children's Health Insurance Program
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Temporary Assistance for Needy Families
- Federal Transit Formula Grants
- National School Lunch Program
- Allergy and Infectious Diseases Research
- Aging Research